Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-21-006278

EVP, Research & Development gave up 3,510 shares (to pay taxes)

  • EVP, Research & Development acquired 4,454 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sandrock Alfred · EVP, Research & Development

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-12 Shares withheld for taxes : show line 1 in the form −1,533 $278.03 $426,220 15,261.21 D
2021-02-12 Exercise or conversion : show line 2 in the form +1,300 16,561.21 D
2021-02-12 Exercise or conversion : show line 3 in the form +1,446 18,007.21 D
2021-02-12 Exercise or conversion : show line 4 in the form +1,708 19,715.21 D
2021-02-12 Shares withheld for taxes : show line 5 in the form −577 $278.03 $160,423 19,138.21 D
2021-02-12 Shares withheld for taxes : show line 6 in the form −642 $278.03 $178,495 18,496.21 D
2021-02-12 Shares withheld for taxes : show line 7 in the form −758 $278.03 $210,747 17,738.21 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2021-02-12 Exercise or conversion : show line 8 in the form Restricted Stock Unit −1,300 1,466 D
2021-02-12 Other disposition : show line 9 in the form Restricted Stock Unit −1,466 0 D
2021-02-12 Exercise or conversion : show line 10 in the form Restricted Stock Unit −1,446 5,442 D
2021-02-12 Other disposition : show line 11 in the form Restricted Stock Unit −1,996 3,446 D
2021-02-12 Exercise or conversion : show line 12 in the form Restricted Stock Unit −1,708 10,352 D
2021-02-12 Other disposition : show line 13 in the form Restricted Stock Unit −2,310 8,042 D
Loading xslF345X03/form4.xml…